These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30503101)

  • 1. Access and benefit sharing--The perspective of basic research.
    Beck E
    Phytomedicine; 2019 Feb; 53():302-307. PubMed ID: 30503101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 25 years after the `Rio Convention'--Lessons learned in the context of sustainable development and protecting indigenous and local knowledge.
    Heinrich M; Hesketh A
    Phytomedicine; 2019 Feb; 53():332-343. PubMed ID: 30318154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of the Nagoya Protocol in the European Union and in Germany.
    Greiber T
    Phytomedicine; 2019 Feb; 53():313-318. PubMed ID: 30392747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Explanation of the Nagoya Protocol on Access and Benefit Sharing and its implication for microbiology.
    Smith D; da Silva M; Jackson J; Lyal C
    Microbiology (Reading); 2017 Mar; 163(3):289-296. PubMed ID: 28086069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who Are Indigenous and Local Communities and What Is Traditional Knowledge for Virus Access and Benefit-sharing? A Textual Analysis of the Convention on Biological Diversity and Its Nagoya Protocol.
    Rourke MF
    J Law Med; 2018 Apr; 25(3):707-726. PubMed ID: 29978663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sharing the benefits of biodiversity: a new international protocol and its implications for research and development.
    Oliva MJ
    Planta Med; 2011 Jul; 77(11):1221-7. PubMed ID: 21674434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The U.S. Culture Collection Network Responding to the Requirements of the Nagoya Protocol on Access and Benefit Sharing.
    McCluskey K; Barker KB; Barton HA; Boundy-Mills K; Brown DR; Coddington JA; Cook K; Desmeth P; Geiser D; Glaeser JA; Greene S; Kang S; Lomas MW; Melcher U; Miller SE; Nobles DR; Owens KJ; Reichman JH; da Silva M; Wertz J; Whitworth C; Smith D
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Governing synthetic biology in the light of the Access and Benefit Sharing regulation (ABS).
    Augusto C; Gutiérrez C
    Rev Derecho Genoma Hum; 2014; (41):63-87. PubMed ID: 25845206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of Nagoya Protocol on access and benefit-sharing in Peru: Implications for researchers.
    Friso F; Mendive F; Soffiato M; Bombardelli V; Hesketh A; Heinrich M; Menghini L; Politi M
    J Ethnopharmacol; 2020 Sep; 259():112885. PubMed ID: 32311487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sharing the benefits of genetic resources: from biodiversity to human genetics.
    Schroeder D; Lasén-Díaz C
    Dev World Bioeth; 2006 Dec; 6(3):135-43. PubMed ID: 17038005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balanced Options for Access and Benefit-Sharing: Stakeholder Insights on Provider Country Legislation.
    Sirakaya A
    Front Plant Sci; 2019; 10():1175. PubMed ID: 31632420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access and Benefit Sharing Under the Nagoya Protocol-
    Heinrich M; Scotti F; Andrade-Cetto A; Berger-Gonzalez M; Echeverría J; Friso F; Garcia-Cardona F; Hesketh A; Hitziger M; Maake C; Politi M; Spadafora C; Spadafora R
    Front Pharmacol; 2020; 11():765. PubMed ID: 32581783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rooibos Benefit Sharing Agreement-Breaking New Ground with Respect, Honesty, Fairness, and Care.
    Schroeder D; Chennells R; Louw C; Snyders L; Hodges T
    Camb Q Healthc Ethics; 2020 Apr; 29(2):285-301. PubMed ID: 31685054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exchange of natural enemies for biological control: is it a rocky road?-the road in the Euro-Mediterranean region and the South American common market.
    Coutinot D; Briano J; Parra JR; de Sá LA; Cônsoli FL
    Neotrop Entomol; 2013 Feb; 42(1):1-14. PubMed ID: 23949707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital Sequence Information and the Access and Benefit-Sharing Obligation of the Convention on Biological Diversity.
    Akpoviri FI; Baharum SN; Zainol ZA
    Nanoethics; 2023; 17(1):1. PubMed ID: 37008389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myth-busting the provider-user relationship for digital sequence information.
    Scholz AH; Lange M; Habekost P; Oldham P; Cancio I; Cochrane G; Freitag J
    Gigascience; 2021 Dec; 10(12):. PubMed ID: 34966927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of Nagoya Protocol on traditional Chinese medicine].
    Yang G; Xu J; Chi XL; Zang CX; Que L
    Zhongguo Zhong Yao Za Zhi; 2018 Jan; 43(2):396-400. PubMed ID: 29552861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genebank Operation in the Arena of Access and Benefit-Sharing Policies.
    Brink M; van Hintum T
    Front Plant Sci; 2019; 10():1712. PubMed ID: 32038684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Including Digital Sequence Data in the Nagoya Protocol Can Promote Data Sharing.
    Ambler J; Diallo AA; Dearden PK; Wilcox P; Hudson M; Tiffin N
    Trends Biotechnol; 2021 Feb; 39(2):116-125. PubMed ID: 32654776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward equality of biodiversity knowledge through technology transfer.
    Böhm M; Collen B
    Conserv Biol; 2015 Oct; 29(5):1290-302. PubMed ID: 25981192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.